DAVID HARPER, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Armata Pharmaceuticals, Inc.

Filing Date Source Excerpt
2014-11-25 David Harper, Ph.D. Includes options to purchase 600,000 shares of common stock.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22